Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Allersys? CE-Mark

8th May 2018 07:00

RNS Number : 2347N
Omega Diagnostics Group PLC
08 May 2018
 

 

Omega Diagnostics Group PLC

("Omega" or the "Company")

 

Allersys® CE-Mark

 

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has CE-Marked two additional allergens, extending the menu to 53 allergens which can be run on the fully automated IDS Instrument.

 

These allergens will be supplied to IDS under the global distribution agreement announced on 20 April 2018. Ongoing investment to increase the menu is supported by the research and development grant of up to £1.8 million, which the Company secured from Scottish Enterprise in August 2016.

 

 

 

Contacts:

 

Omega Diagnostics Group PLC

Tel: 01259 763 030

Colin King, Chief Executive

www.omegadiagnostics.com

Kieron Harbinson, Group Finance Director

 

finnCap Ltd

Tel: 020 7220 0500

Geoff Nash/James Thompson (Corporate Finance)

Camille Gochez/ Abigail Wayne (Corporate Broking)

Walbrook PR Limited

Tel: 020 7933 8780 or [email protected]

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFMGGKKDNGRZM

Related Shares:

ODX.L
FTSE 100 Latest
Value8,809.74
Change53.53